Townsville University Hospital serves as North Queensland's major medical hub, managing Hepatitis C patients from across the vast Townsville and North West Queensland Hospital and Health Service. Townsville's significant Aboriginal and Torres Strait Islander community — with higher HCV prevalence — makes affordable Resof L access a genuine health equity priority for the region.
North Queensland's isolation from major cities and limited specialist hepatology services make community-based HCV treatment, supported by affordable generic medicines, essential for reaching all patients who need curative therapy. Resof L at dramatically lower cost than brand Harvoni enables GPs and community health services to support more complete treatment courses without cost-related dropout.
Visit medshopy.com or WhatsApp +91 82650 41513 for Townsville and North Queensland supply.
What is the WHO global Hepatitis C elimination target and is Australia on track to achieve it?
North Queensland's isolation from major cities and limited specialist hepatology services make community-based HCV treatment, supported by affordable generic medicines, essential for reaching all patients who need curative therapy. Resof L at dramatically lower cost than brand Harvoni enables GPs and community health services to support more complete treatment courses without cost-related dropout.
Visit medshopy.com or WhatsApp +91 82650 41513 for Townsville and North Queensland supply.
What is the WHO global Hepatitis C elimination target and is Australia on track to achieve it?The WHO set a 2030 target to eliminate Hepatitis C as a public health threat, defined as a 90% reduction in new infections and 65% reduction in HCV-related deaths compared to 2015 baselines. Australia is actually one of the countries most advanced in progress toward this goal — largely due to its early and comprehensive universal DAA access programme launched in 2016, which removed restrictions based on liver fibrosis stage or drug use history. Australia has treated over 90,000 people with DAA therapy and has achieved significant reductions in HCV diagnoses, particularly in populations that were previously difficult to treat. Challenges remain in reaching Indigenous communities, people in correctional facilities, and those with ongoing injection drug use — which is why community-based treatment delivery in regional centres like Townsville is critical to completing the elimination journey.
